Your browser doesn't support javascript.
loading
Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcoma.
Assi, Tarek; Ibrahim, Rebecca; Ibrahim, Toni; Khoury, Rita; Cesne, Axel Le.
Affiliation
  • Assi T; Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ibrahim R; Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ibrahim T; Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
  • Khoury R; Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
  • Cesne AL; Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.
Immunotherapy ; 15(14): 1089-1091, 2023 10.
Article in En | MEDLINE | ID: mdl-37585663
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Hemangiosarcoma Limits: Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Hemangiosarcoma Limits: Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: